Bixiye
P57-17 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Natiijooyinka Raadinta
Soo bandhiga 3251 - 3260 ee natiijooyinka 3688
Bixiye
P39-17 Concurrent Review for Inpatient Hospital Services at Select Facilities
Taariikhda dhaqangalka Barnaamijka: Jul 11, 2017
Bixiye
P62-16 EY Modifier for Platinum Blue Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2016
Bixiye
P48-16 Criteria Changes to Certain Services on the Prior Authorization List for MHCP Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 26, 2016
Bixiye
P20-17 New Drug-Related Prior Authorization Criteria for QVAR (beclomethasone dipropionate HFA)
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2017
Bixiye
P37-17 Update to Attachment B: Definition of Outpatient Health Services Categories
Taariikhda wax ku ool ah ee barnaamijka: Jun 22, 2017
Bixiye
P66-17 Clarification of Mid-Level Definitions
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P17-17 Addition of Drug Kisqali to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2017
Bixiye
P22-17 Identified Claims Processing Issues Grid
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2017
Bixiye
P35-16 Requirement to Submit National Drug Codes and Related Information
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2016